Security key
52886N406
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 1,717,317
- Total 13F value
- $1,634,673
- Share change
- -580,133
- SEC-reported price per share
- $0.95
- Number of holders
- 25
- Value change
- -$453,765
- Number of buys
- 13
- Number of sells
- 5
Report period
Q3 2025
Institutions
25
Top holders
10
LEXX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Lexaria Bioscience Corp. SEC filings
Lexaria Bioscience Corp. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 52886N406
Recent filing periods:
Ownership snapshot
Top reported holders of LEXX - Lexaria Bioscience Corp. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
0/15
Latest evidence
29 Jul 2025
13F
3/4/5
Highest disclosed value: $1,013,675
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
SABBY MANAGEMENT, LLC has the largest disclosed position value at $1.01M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Disclosed position value
Top 5
SABBY MANAGEMENT, LLC
$1.01M
Invenomic Capital Management LP
$436.3K
Richard Christopher
$363.6K
John Martin Docherty
$322.5K
GEODE CAPITAL MANAGEMENT, LLC
$152.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$1,013,675
1,165,144 shares
|
— | 30 Jun 2025 |
| Invenomic Capital Management LP |
13F
Company
|
—
class O/S missing
|
$436,277
501,468 shares
|
— | 30 Jun 2025 |
| Richard Christopher |
3/4/5
Chief Executive Officer, Director
|
—
mixed-class rows
|
$363,611
415,000 shares
mixed-class rows
|
— | 29 Jul 2025 |
| John Martin Docherty |
3/4/5
President & CSO, Director
|
—
mixed-class rows
|
$322,458
370,285 shares
mixed-class rows
|
— | 29 Jul 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$152,087
174,779 shares
|
— | 30 Jun 2025 |
| Michael Elliot Shankman |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
$122,000
100,000 shares
|
— | 15 May 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
1,717,317
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q1 2026 Across Filers
Q1 2026 holders
28
Q3 2025 holders
25
Holder diff
-3
| Investor | Q1 2026 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend